111 (YI) EBITDA Margin Growth (3y) (2020 - 2025)
111 (YI) EBITDA Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 81.00 |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 58.00 |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -30.00 |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -32.00 |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 694.00 |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 278.00 |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 224.00 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -1,629.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 224.00 |
| Sep 30, 2025 | 216.00 |
| Jun 30, 2025 | 225.00 |
| Mar 31, 2025 | 323.00 |
| Dec 31, 2024 | -44.00 |
| Sep 30, 2024 | 701.00 |
| Jun 30, 2024 | 497.00 |
| Mar 31, 2024 | 522.00 |
| Dec 31, 2023 | -74.00 |
| Sep 30, 2023 | 278.00 |
| Jun 30, 2023 | 437.00 |
| Mar 31, 2023 | 607.00 |
| Dec 31, 2022 | -1,541.00 |
| Sep 30, 2022 | -1,180.00 |
| Jun 30, 2022 | -1,232.00 |
| Mar 31, 2022 | -2,500.00 |
| Dec 31, 2021 | -2,273.00 |
| Sep 30, 2021 | -2,881.00 |
| Jun 30, 2021 | 1,482.00 |
| Mar 31, 2021 | 568.00 |